Antengene appoints Kathryn Gregory as Head of Corp biz development
China-based Antengene Corporation has announced the appointment of Kathryn Gregory as Vice President and Head of Corporate Business Development, reporting to John F. Chin, Chief Business Officer of Antengene. In this role, Kathryn will be responsible for leading external business development including in/out-licensing, co-development/ commercialization, mergers and acquisitions, and other collaboration agreements supporting Antengene’s objectives. Kathryn has over 25 years of executive leadership experience in the global biopharmaceutical industry. She has extensive experience in international business development including corporate strategy, negotiation, mergers and acquisitions, alliance management; and operational experience in marketing, strategic sourcing and procurement. Prior to joining Antengene, Kathryn was the Chief Business Officer at Aileron Therapeutics. During her tenure, she led negotiations for regional partnerships in Europe and Asia for anticancer and chemoprotection programmes and developed key relationships with large pharmaceutical and biotechnology firms.